Polar Asset Management Partners’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.8M Buy
1,550,000
+50,000
+3% +$507K 0.26% 65
2026
Q2
$15.1M Hold
1,500,000
– – 0.25% 87
2026
Q1
$15M Hold
1,500,000
– – 0.3% 63
2025
Q4
$14.8M Buy
+1,500,000
New +$14.8M 0.19% 95

Other funds holding DMII

Polar Asset Management Partners's DMII Position: Q3 2026 in Review

Polar Asset Management Partners increased its Drugs Made In America Acquisition II Corp (DMII) stake by 3.3% in Q3 2026, buying an estimated $507K and bringing the position to 1,550,000 shares worth $15.8M. The position accounts for 0.26% of the portfolio, ranked #65.

Polar Asset Management Partners first reported a position in DMII in Q4 2025 and has held it in 4 quarters since. 66 funds tracked by Wall St. Rank hold DMII as of Q3 2026.

  • Polar Asset Management Partners held 1,550,000 shares of Drugs Made In America Acquisition II Corp worth $15.8M as of Q3 2026.
  • Polar Asset Management Partners bought 50,000 Drugs Made In America Acquisition II Corp shares in Q3 2026, an estimated $507K.
  • Drugs Made In America Acquisition II Corp made up 0.26% of Polar Asset Management Partners's portfolio in Q3 2026, its #65 holding.
  • Polar Asset Management Partners first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 4 quarters since.
  • 66 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q3 2026.

Based on Polar Asset Management Partners's 13F filing for Q3 2026, filed 16 Nov 2026.